Sarah Bick
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sarah Bick has a total of 207 co-authors. Here are the top co-authors by number of shared publications:
- Dario J. Englot
Department of Neurological Surgery Vanderbilt University Medical Center Nashville Tennessee USA
9 shared publications - Christos Constantinidis
Department of Biomedical Engineering, Vanderbilt University, Nashville, USA
7 shared publications Dario J. Englot
Department of Neurological Surgery, Vanderbilt Health, Nashville, TN, USA; Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA
7 shared publicationsNatasha C. Hughes
Vanderbilt University School of Medicine, Nashville, TN, USA; Department of Neurological Surgery, Massachusetts General Hospital, Boston, MA, USA
7 shared publications- Graham W. Johnson
Department of Neurologic Surgery, Mayo Clinic, Rochester, MN
6 shared publications Helen Qian
Department of Neurosurgery, Vanderbilt University Medical Center, Nashville, TN, USA
6 shared publications
Latest Publications
- Open Access
- 30 July 2026
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 270, 109600
Postoperative outcomes in patients with dementia undergoing deep brain stimulation: A retrospective matched cohort study
- 30 July 2026
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 270, 109600
Open AccessPostoperative outcomes in patients with dementia undergoing deep brain stimulation: A retrospective matched cohort study
- Open Access
- 1 July 2026
- Published by Society for Neuroscience in eneuro
- Vol. 13 (7)
Movement Disorder Patients with Depression have Altered Corticostriatal Alpha-Beta Power Response to Reward and Loss
Depression is a common comorbidity in movement disorders such as Parkinson’s disease (PD) and essential tremor (ET). Altered reward signaling contributes to core depression symptoms such as anhedonia, but the specific neural activity patterns underlying these processes and how they manifest in comorbid movement disorders are incompletely understood. Fourteen PD patients and 16 ET patients (22 male, 8 female) participated while undergoing deep brain stimulation surgery. Subjects completed a working memory task and received visual feedback about response accuracy while signals were recorded from traversed structures (caudate and/or dorsolateral prefrontal cortex (DLPFC)). Preoperative Beck Depression Inventory-II (BDI-II) scores of ≥14 indicated elevated depression symptoms. Using cluster-based permutation testing, we identified time and frequency ranges in which oscillatory power significantly differed during reward versus loss feedback. We then used two-way ANOVAs and linear mixed effects models to assess how these power changes differed based on movement disorder and depression severity. Caudate and DLPFC alpha-beta (8-30 Hz) power increased during reward feedback. In both regions, this increase was attenuated in depressed subjects [caudate difference=-0.22, 95% CI=-0.32 to -0.13; DLPFC difference=-0.10, 95% CI=-0.16 to -0.045]. BDI-II score was a negative predictor of reward- and loss-related corticostriatal alpha-beta power [caudate estimate=-0.014, 95% CI=-0.020 to -0.0078; DLPFC estimate=-0.0075, 95% CI=-0.012 to -0.0029]. Specific to PD, depressed patients had greater decreases in DLPFC alpha-beta power following loss feedback than non-depressed patients [difference=-0.10, 95% CI=-0.17 to -0.027]. Our findings suggest that altered corticostriatal alpha-beta power may contribute to reward dysfunction in depression in patients with movement disorders. Significance statement Depression is prevalent in both the general population and patients with movement disorders such as Parkinson’s disease (PD) and essential tremor (ET). Imaging studies have suggested that patients with depression have altered reward processing, but our understanding of the neural activity underlying this effect and its manifestation in comorbid neurological disorders is limited. Using intracranial EEG recordings in movement disorder patients, we show that depression symptom severity predicts altered corticostriatal alpha-beta oscillatory power (8-30 Hz) reward signaling and that depressed PD patients show heightened alpha-beta power response to loss feedback. Our findings implicate alpha-beta power attenuation within corticostriatal circuits as a potential therapeutic target for guiding novel treatment development for treatment-resistant depression and the comorbid depression symptoms of movement disorders.
- 1 July 2026
- Published by Society for Neuroscience in eneuro
- Vol. 13 (7)
Open AccessMovement Disorder Patients with Depression have Altered Corticostriatal Alpha-Beta Power Response to Reward and Loss
Depression is a common comorbidity in movement disorders such as Parkinson’s disease (PD) and essential tremor (ET). Altered reward signaling contributes to core depression symptoms such as anhedonia, but the specific neural activity patterns underlying these processes and how they manifest in comorbid movement disorders are incompletely understood. Fourteen PD patients and 16 ET patients (22 male, 8 female) participated while undergoing deep brain stimulation surgery. Subjects completed a working memory task and received visual feedback about response accuracy while signals were recorded from traversed structures (caudate and/or dorsolateral prefrontal cortex (DLPFC)). Preoperative Beck Depression Inventory-II (BDI-II) scores of ≥14 indicated elevated depression symptoms. Using cluster-based permutation testing, we identified time and frequency ranges in which oscillatory power significantly differed during reward versus loss feedback. We then used two-way ANOVAs and linear mixed effects models to assess how these power changes differed based on movement disorder and depression severity. Caudate and DLPFC alpha-beta (8-30 Hz) power increased during reward feedback. In both regions, this increase was attenuated in depressed subjects [caudate difference=-0.22, 95% CI=-0.32 to -0.13; DLPFC difference=-0.10, 95% CI=-0.16 to -0.045]. BDI-II score was a negative predictor of reward- and loss-related corticostriatal alpha-beta power [caudate estimate=-0.014, 95% CI=-0.020 to -0.0078; DLPFC estimate=-0.0075, 95% CI=-0.012 to -0.0029]. Specific to PD, depressed patients had greater decreases in DLPFC alpha-beta power following loss feedback than non-depressed patients [difference=-0.10, 95% CI=-0.17 to -0.027]. Our findings suggest that altered corticostriatal alpha-beta power may contribute to reward dysfunction in depression in patients with movement disorders. Significance statement Depression is prevalent in both the general population and patients with movement disorders such as Parkinson’s disease (PD) and essential tremor (ET). Imaging studies have suggested that patients with depression have altered reward processing, but our understanding of the neural activity underlying this effect and its manifestation in comorbid neurological disorders is limited. Using intracranial EEG recordings in movement disorder patients, we show that depression symptom severity predicts altered corticostriatal alpha-beta oscillatory power (8-30 Hz) reward signaling and that depressed PD patients show heightened alpha-beta power response to loss feedback. Our findings implicate alpha-beta power attenuation within corticostriatal circuits as a potential therapeutic target for guiding novel treatment development for treatment-resistant depression and the comorbid depression symptoms of movement disorders.
- Open Access
- 21 May 2026
- Published by S. Karger AG in Stereotactic and Functional Neurosurgery
- p. 1-14
Nonmotor Symptoms in Parkinson’s Disease: Neurophysiology Biomarkers and Neuromodulation Approaches
Background: Parkinson’s disease (PD) is the second most common neurodegenerative disorder, with increasing global incidence and prevalence. While PD is diagnosed based on the presence of classic motor symptoms including tremor, bradykinesia, and rigidity, non-motor symptoms also play an important role in disease pathogenesis. Increasing evidence has demonstrated that non-motor symptoms, including neuropsychiatric changes, cognitive impairment, sleep disturbances, autonomic dysfunction, and pain and sensory symptoms, significantly affect PD patients’ disease burden, quality of life, and utilization of healthcare resources. Summary: Deep brain stimulation (DBS) is an effective treatment for motor symptoms in advanced PD. The neurophysiology changes associated with PD motor symptoms are relatively well understood and have been used to inform closed-loop DBS approaches to improve motor symptom control. Unfortunately, effective treatments for many of the non-motor symptoms of advanced PD are lacking, and DBS to treat motor symptoms may worsen non-motor symptoms such as depression, cognitive impairment, and impulsive and compulsive behaviors in some patients. Key Messages: Recent work has provided some insight into neurophysiological changes underlying nonmotor symptoms, which may inform development of future therapeutic approaches. In this manuscript, we review neurophysiology biomarkers associated with non-motor symptoms and their application to developing novel neuromodulation treatments. We additionally review how existing DBS approaches may impact non-motor symptoms. We highlight the need for precise and individualized neuromodulation approaches.
- 21 May 2026
- Published by S. Karger AG in Stereotactic and Functional Neurosurgery
- p. 1-14
Open AccessNonmotor Symptoms in Parkinson’s Disease: Neurophysiology Biomarkers and Neuromodulation Approaches
Background: Parkinson’s disease (PD) is the second most common neurodegenerative disorder, with increasing global incidence and prevalence. While PD is diagnosed based on the presence of classic motor symptoms including tremor, bradykinesia, and rigidity, non-motor symptoms also play an important role in disease pathogenesis. Increasing evidence has demonstrated that non-motor symptoms, including neuropsychiatric changes, cognitive impairment, sleep disturbances, autonomic dysfunction, and pain and sensory symptoms, significantly affect PD patients’ disease burden, quality of life, and utilization of healthcare resources. Summary: Deep brain stimulation (DBS) is an effective treatment for motor symptoms in advanced PD. The neurophysiology changes associated with PD motor symptoms are relatively well understood and have been used to inform closed-loop DBS approaches to improve motor symptom control. Unfortunately, effective treatments for many of the non-motor symptoms of advanced PD are lacking, and DBS to treat motor symptoms may worsen non-motor symptoms such as depression, cognitive impairment, and impulsive and compulsive behaviors in some patients. Key Messages: Recent work has provided some insight into neurophysiological changes underlying nonmotor symptoms, which may inform development of future therapeutic approaches. In this manuscript, we review neurophysiology biomarkers associated with non-motor symptoms and their application to developing novel neuromodulation treatments. We additionally review how existing DBS approaches may impact non-motor symptoms. We highlight the need for precise and individualized neuromodulation approaches.
- 9 December 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 105 (11) , e214385
Altered Interictal Bed Nucleus of Stria Terminalis Connectivity in Patients With Temporal Lobe Epilepsy
Temporal lobe epilepsy (TLE) is a highly prevalent neurologic disorder, with 30%-50% of patients developing drug-resistant epilepsy. Pharmacoresistant seizures remodel critical arousal and respiratory networks, impairing autonomic function and chemoreception and putting patients at increased risk of adverse respiratory events and sudden unexpected death (SUDEP). Given that the bed nucleus of stria terminalis (BNST) serves as a key relay between brainstem respiratory nuclei and cortical arousal networks, we characterized interictal BNST connectivity alterations in patients with TLE. We conducted a case-control study of patients with drug-resistant TLE evaluated for epilepsy surgery at Vanderbilt University Medical Center, compared with healthy controls with no history of neurologic disease. Inclusion criteria for patients included clinical TLE diagnosis and age 18-65 years. Using resting-state fMRI (multiband factor = 3, repetition time [TR] = 1.3 seconds), we measured functional connectivity (FC) and effective connectivity through Granger causality (GC) between BNST and whole-brain cortical networks, and brainstem nuclei. Graph theoretical network metrics assessed BNST hub properties. Statistical analyses used multiple comparison corrections and age-corrected z-scores. Thirty-seven patients with TLE (mean age 42.5 ± 12.1 years, 43.2% female) and 33 healthy controls (mean age 36.2 ± 12.0 years, 54.5% female) were studied. Patients demonstrated bilateral reductions in BNST connectivity and causal influence with the whole brain (FC: -2.31 ± 2.87, p = 0.0032; GC: -0.18 ± 0.08, p = 0.0025). While FC showed preserved BNST-brainstem connectivity, GC revealed ipsilateral disruptions in BNST influence over ventral tegmental area (0.023 ± 0.026, p = 0.0067), median raphe (-0.009 ± 0.029, p = 0.0038), and cuneiform nuclei (0.012 ± 0.062, p = 0.0153). Critical respiratory circuits showed divergent reorganization: dorsal raphe-parabrachial complex pathways exhibited 57.2% efferent reduction (p = 0.0028), with 204.6% compensatory afferent increase (p = 0.0020), while dorsal raphe-locus coeruleus circuits showed bilateral deterioration (66.2% reduction in dorsal raphe-locus coeruleus [DR→LC], p = 0.0015; 56.4% reduction in LC→DR, p = 0.0189). Graph analyses confirmed compromised BNST network integration bilaterally (p < 0.05). Our findings reveal network reorganization in TLE that compromises autonomic and arousal circuit integrity, leading to failed respiratory-autonomic integration that may underlie respiratory vulnerability and increased SUDEP risk; however, we did not directly study SUDEP cases.
- 9 December 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 105 (11) , e214385
Altered Interictal Bed Nucleus of Stria Terminalis Connectivity in Patients With Temporal Lobe Epilepsy
Temporal lobe epilepsy (TLE) is a highly prevalent neurologic disorder, with 30%-50% of patients developing drug-resistant epilepsy. Pharmacoresistant seizures remodel critical arousal and respiratory networks, impairing autonomic function and chemoreception and putting patients at increased risk of adverse respiratory events and sudden unexpected death (SUDEP). Given that the bed nucleus of stria terminalis (BNST) serves as a key relay between brainstem respiratory nuclei and cortical arousal networks, we characterized interictal BNST connectivity alterations in patients with TLE. We conducted a case-control study of patients with drug-resistant TLE evaluated for epilepsy surgery at Vanderbilt University Medical Center, compared with healthy controls with no history of neurologic disease. Inclusion criteria for patients included clinical TLE diagnosis and age 18-65 years. Using resting-state fMRI (multiband factor = 3, repetition time [TR] = 1.3 seconds), we measured functional connectivity (FC) and effective connectivity through Granger causality (GC) between BNST and whole-brain cortical networks, and brainstem nuclei. Graph theoretical network metrics assessed BNST hub properties. Statistical analyses used multiple comparison corrections and age-corrected z-scores. Thirty-seven patients with TLE (mean age 42.5 ± 12.1 years, 43.2% female) and 33 healthy controls (mean age 36.2 ± 12.0 years, 54.5% female) were studied. Patients demonstrated bilateral reductions in BNST connectivity and causal influence with the whole brain (FC: -2.31 ± 2.87, p = 0.0032; GC: -0.18 ± 0.08, p = 0.0025). While FC showed preserved BNST-brainstem connectivity, GC revealed ipsilateral disruptions in BNST influence over ventral tegmental area (0.023 ± 0.026, p = 0.0067), median raphe (-0.009 ± 0.029, p = 0.0038), and cuneiform nuclei (0.012 ± 0.062, p = 0.0153). Critical respiratory circuits showed divergent reorganization: dorsal raphe-parabrachial complex pathways exhibited 57.2% efferent reduction (p = 0.0028), with 204.6% compensatory afferent increase (p = 0.0020), while dorsal raphe-locus coeruleus circuits showed bilateral deterioration (66.2% reduction in dorsal raphe-locus coeruleus [DR→LC], p = 0.0015; 56.4% reduction in LC→DR, p = 0.0189). Graph analyses confirmed compromised BNST network integration bilaterally (p < 0.05). Our findings reveal network reorganization in TLE that compromises autonomic and arousal circuit integrity, leading to failed respiratory-autonomic integration that may underlie respiratory vulnerability and increased SUDEP risk; however, we did not directly study SUDEP cases.
- Open Access
- 1 November 2025
- Published by Taylor & Francis in International Medical Case Reports Journal
- Vol. ume 18, 1429-1438
Deep Brain Stimulation Peri Lead Cyst Resolution with Nonoperative Management: Case Report and Review of the Literature
Deep brain stimulation (DBS) is an effective treatment for medically refractory essential tremor (ET) and Parkinson’s disease. We present the case of a patient treated with thalamic DBS for ET who developed a large right peri-lead cyst with associated edema three months postoperatively, causing symptoms of dysarthria and left-sided weakness. The patient was treated nonoperatively with a course of steroids and serial observation. Over three months, the cyst regressed in size, with resolution of the associated symptoms. The patient was ultimately able to continue bilateral DBS for ET, which provided relief from upper-extremity tremor. By 9 months after the cyst was diagnosed (one year postoperatively from DBS) he was fully recovered back to baseline. We review other cases of peri-lead cysts and edema, of which etiology and presentation remain varied and unclear. Peri-lead cysts are a rare complication of DBS with an estimated incidence of 0.8%. Ultimately, this case shows that appropriately selected peri-lead cysts may be managed nonoperatively, allowing for continued DBS benefit in patients by avoiding lead removal.
- 1 November 2025
- Published by Taylor & Francis in International Medical Case Reports Journal
- Vol. ume 18, 1429-1438
Open AccessDeep Brain Stimulation Peri Lead Cyst Resolution with Nonoperative Management: Case Report and Review of the Literature
Deep brain stimulation (DBS) is an effective treatment for medically refractory essential tremor (ET) and Parkinson’s disease. We present the case of a patient treated with thalamic DBS for ET who developed a large right peri-lead cyst with associated edema three months postoperatively, causing symptoms of dysarthria and left-sided weakness. The patient was treated nonoperatively with a course of steroids and serial observation. Over three months, the cyst regressed in size, with resolution of the associated symptoms. The patient was ultimately able to continue bilateral DBS for ET, which provided relief from upper-extremity tremor. By 9 months after the cyst was diagnosed (one year postoperatively from DBS) he was fully recovered back to baseline. We review other cases of peri-lead cysts and edema, of which etiology and presentation remain varied and unclear. Peri-lead cysts are a rare complication of DBS with an estimated incidence of 0.8%. Ultimately, this case shows that appropriately selected peri-lead cysts may be managed nonoperatively, allowing for continued DBS benefit in patients by avoiding lead removal.
- 1 September 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 143 (3) , 718-727
Intraoperative neural firing correlates with motor and cognitive features in Parkinson’s disease
OBJECTIVE: During deep brain stimulation (DBS) surgery for Parkinson’s disease (PD), intraoperative microelectrode recordings (MERs) are frequently used to determine electrode positioning within the subthalamic nucleus (STN) and globus pallidus internus (GPi). Various patient characteristics might be associated with abnormal STN and GPi firing activity and thus influence electrode placement. In this study, the authors aimed to elucidate the relationship between preoperative dopamine responsiveness or changes in cognitive status and STN or GPi multiunit activity. METHODS: This retrospective cohort study included patients with PD undergoing awake STN (n = 74) or GPi (n = 63) DBS surgery with intraoperative MER at a single institution from 2013 to 2021. To control for the lead position, contralateral motor outcomes of each lead were graded using 1-year neurological follow-up notes. Multiunit neural firing activity for each lead was recorded from MER at the location corresponding to lead active contact at the 1-year follow-up assessment. Linear regression models, controlling for disease duration and age, were used to identify associations between multiunit neural firing rates and preoperative dopamine responsiveness, determined by the difference between preoperative motor scores when on medication minus preoperative motor scores when off medication, and between multiunit activity and the pre- to postoperative change in Mini-Mental State Examination scores. RESULTS: Seventy-four patients with 130 STN leads (mean age 61.2 ± 10.4 years) and 63 patients with 110 GPi leads (mean age 62.8 ± 8.6 years) were included. In STN leads with maximum contralateral motor improvement, increased dopamine responsiveness was associated with both the intraoperative firing rate (p = 0.01) and disease duration (p = 0.01). These relationships were not significant in the GPi leads or when looking at leads for which patients experienced suboptimal motor improvement (p > 0.05). In the GPi leads, an increased intraoperative firing rate in electrodes with maximum symptom improvement was associated with declining cognitive status (p = 0.045). CONCLUSIONS: These findings suggest patient characteristics that correlate with neural firing rates and influence intraoperative MER, final electrode placement, and patient outcomes, while improving understanding of STN and GPi pathophysiologic mechanisms in PD. Future investigations into other characteristics that might affect STN and GPi intraoperative neurophysiology are warranted.
- 1 September 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 143 (3) , 718-727
Intraoperative neural firing correlates with motor and cognitive features in Parkinson’s disease
OBJECTIVE: During deep brain stimulation (DBS) surgery for Parkinson’s disease (PD), intraoperative microelectrode recordings (MERs) are frequently used to determine electrode positioning within the subthalamic nucleus (STN) and globus pallidus internus (GPi). Various patient characteristics might be associated with abnormal STN and GPi firing activity and thus influence electrode placement. In this study, the authors aimed to elucidate the relationship between preoperative dopamine responsiveness or changes in cognitive status and STN or GPi multiunit activity. METHODS: This retrospective cohort study included patients with PD undergoing awake STN (n = 74) or GPi (n = 63) DBS surgery with intraoperative MER at a single institution from 2013 to 2021. To control for the lead position, contralateral motor outcomes of each lead were graded using 1-year neurological follow-up notes. Multiunit neural firing activity for each lead was recorded from MER at the location corresponding to lead active contact at the 1-year follow-up assessment. Linear regression models, controlling for disease duration and age, were used to identify associations between multiunit neural firing rates and preoperative dopamine responsiveness, determined by the difference between preoperative motor scores when on medication minus preoperative motor scores when off medication, and between multiunit activity and the pre- to postoperative change in Mini-Mental State Examination scores. RESULTS: Seventy-four patients with 130 STN leads (mean age 61.2 ± 10.4 years) and 63 patients with 110 GPi leads (mean age 62.8 ± 8.6 years) were included. In STN leads with maximum contralateral motor improvement, increased dopamine responsiveness was associated with both the intraoperative firing rate (p = 0.01) and disease duration (p = 0.01). These relationships were not significant in the GPi leads or when looking at leads for which patients experienced suboptimal motor improvement (p > 0.05). In the GPi leads, an increased intraoperative firing rate in electrodes with maximum symptom improvement was associated with declining cognitive status (p = 0.045). CONCLUSIONS: These findings suggest patient characteristics that correlate with neural firing rates and influence intraoperative MER, final electrode placement, and patient outcomes, while improving understanding of STN and GPi pathophysiologic mechanisms in PD. Future investigations into other characteristics that might affect STN and GPi intraoperative neurophysiology are warranted.
- Open Access
- 22 August 2025
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 139, 108008
Relationship between VMAT2-PET and DAT-SPECT caudate binding and Parkinson's disease cognitive decline
- 22 August 2025
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 139, 108008
Open AccessRelationship between VMAT2-PET and DAT-SPECT caudate binding and Parkinson's disease cognitive decline
- 1 July 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 143 (1) , 38-52
Effect of deep brain stimulation on nonmotor symptoms in essential tremor
OBJECTIVE: Essential tremor (ET) is a prevalent movement disorder that also includes nonmotor symptoms such as anxiety, depression, and cognitive impairment. Deep brain stimulation (DBS) is an established treatment for ET, yet its impact on nonmotor symptoms remains unclear. This study aims to describe neuropsychological outcomes following ventral intermediate nucleus (VIM) DBS in a large cohort of patients with ET and identify factors associated with changes in depression and cognitive function. METHODS: A retrospective cohort study of patients who had undergone VIM DBS was performed. Inclusion criteria were ET diagnosis, surgery between October 2007 and March 2020, and available pre- and post-DBS neuropsychological testing results. Neuropsychological measures included the Beck Depression Inventory–II (BDI-II), Beck Anxiety Inventory (BAI), and cognitive measures assessing attention, executive function, language, memory, and visuospatial function. Post-DBS tremor improvement was graded, and active electrode coordinates and stimulation parameters were identified. Statistical analyses included descriptive statistics, t-tests to compare pre- and postoperative scores at the group level, and one-way analysis of variance to compare variables among patients who improved, were stable, or worsened in psychiatric and cognitive characteristics after DBS. RESULTS: One hundred thirty-nine patients met the study inclusion criteria. BDI-II scores significantly decreased postoperatively (9.82 ± 6.77 vs 8.29 ± 6.18, p < 0.001, Cohen’s d = 0.176), whereas BAI scores remained unchanged. Both language (p = 0.003, Cohen’s d = 0.259) and memory (p < 0.001, Cohen’s d = 0.336) domains showed statistically significant small-magnitude declines following surgery, whereas attention, executive function, and visuospatial function were unchanged. Patients with improved depression (14.3%) following VIM DBS had significantly higher BDI-II scores preoperatively (p < 0.001, ω 2 = 0.226). Patients with worsened language (18.7%) had higher preoperative language scores (p < 0.001, ω 2 = 0.058). Patients with worsened memory (15.1%) had higher BAI scores preoperatively (p = 0.002, ω 2 = 0.079). Preoperative scores were similar between patients with improved and worsened overall cognition postsurgery. Patients with improved overall cognition had improvements in attention, language, and visuospatial function. CONCLUSIONS: VIM DBS for ET did not result in large-magnitude neuropsychological changes. There were statistically significant, though likely not clinically meaningful, small-magnitude improvements in depression and worsening in language and memory scores. Associations were found between multiple preoperative mood and cognitive scores and post-DBS neuropsychological changes. These findings can help inform clinical decision-making and patient counseling for DBS.
- 1 July 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 143 (1) , 38-52
Effect of deep brain stimulation on nonmotor symptoms in essential tremor
OBJECTIVE: Essential tremor (ET) is a prevalent movement disorder that also includes nonmotor symptoms such as anxiety, depression, and cognitive impairment. Deep brain stimulation (DBS) is an established treatment for ET, yet its impact on nonmotor symptoms remains unclear. This study aims to describe neuropsychological outcomes following ventral intermediate nucleus (VIM) DBS in a large cohort of patients with ET and identify factors associated with changes in depression and cognitive function. METHODS: A retrospective cohort study of patients who had undergone VIM DBS was performed. Inclusion criteria were ET diagnosis, surgery between October 2007 and March 2020, and available pre- and post-DBS neuropsychological testing results. Neuropsychological measures included the Beck Depression Inventory–II (BDI-II), Beck Anxiety Inventory (BAI), and cognitive measures assessing attention, executive function, language, memory, and visuospatial function. Post-DBS tremor improvement was graded, and active electrode coordinates and stimulation parameters were identified. Statistical analyses included descriptive statistics, t-tests to compare pre- and postoperative scores at the group level, and one-way analysis of variance to compare variables among patients who improved, were stable, or worsened in psychiatric and cognitive characteristics after DBS. RESULTS: One hundred thirty-nine patients met the study inclusion criteria. BDI-II scores significantly decreased postoperatively (9.82 ± 6.77 vs 8.29 ± 6.18, p < 0.001, Cohen’s d = 0.176), whereas BAI scores remained unchanged. Both language (p = 0.003, Cohen’s d = 0.259) and memory (p < 0.001, Cohen’s d = 0.336) domains showed statistically significant small-magnitude declines following surgery, whereas attention, executive function, and visuospatial function were unchanged. Patients with improved depression (14.3%) following VIM DBS had significantly higher BDI-II scores preoperatively (p < 0.001, ω 2 = 0.226). Patients with worsened language (18.7%) had higher preoperative language scores (p < 0.001, ω 2 = 0.058). Patients with worsened memory (15.1%) had higher BAI scores preoperatively (p = 0.002, ω 2 = 0.079). Preoperative scores were similar between patients with improved and worsened overall cognition postsurgery. Patients with improved overall cognition had improvements in attention, language, and visuospatial function. CONCLUSIONS: VIM DBS for ET did not result in large-magnitude neuropsychological changes. There were statistically significant, though likely not clinically meaningful, small-magnitude improvements in depression and worsening in language and memory scores. Associations were found between multiple preoperative mood and cognitive scores and post-DBS neuropsychological changes. These findings can help inform clinical decision-making and patient counseling for DBS.
- 24 June 2025
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 12 (10) , 1460-1462
A Systematic Approach to Evaluating and Addressing Disparities in Deep Brain Stimulation
- 24 June 2025
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 12 (10) , 1460-1462
A Systematic Approach to Evaluating and Addressing Disparities in Deep Brain Stimulation
- Open Access
- 25 April 2025
- Published by Elsevier in NeuroImage
- Vol. 313, 121240
Increased frontoparietal activity related to lower performance in neuropsychological assessment of working memory
- 25 April 2025
- Published by Elsevier in NeuroImage
- Vol. 313, 121240
Open AccessIncreased frontoparietal activity related to lower performance in neuropsychological assessment of working memory